{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:57:17Z","timestamp":1790773037134,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:00:00Z","timestamp":1535155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10096-018-3362-z","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T13:00:11Z","timestamp":1535202011000},"page":"2201-2210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Molecular characterization of fluoroquinolones, macrolides, and imipenem resistance in Haemophilus influenzae: analysis of the mutations in QRDRs and assessment of the extent of the AcrAB-TolC-mediated resistance"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-5935","authenticated-orcid":false,"given":"Abdessalam","family":"Cherkaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Ga\u00efa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Ruppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Schrenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,25]]},"reference":[{"issue":"Suppl 4","key":"3362_CR1","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1086\/430783","volume":"41","author":"RP Rennie","year":"2005","unstructured":"Rennie RP, Ibrahim KH (2005) Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? Commentary on antimicrobial resistance in H. Influenzae based on data from the TARGETed surveillance program. Clin Infect Dis 41(Suppl 4):S234\u2013S238","journal-title":"Clin Infect Dis"},{"issue":"11","key":"3362_CR2","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1128\/JCM.05476-11","volume":"49","author":"A Agrawal","year":"2011","unstructured":"Agrawal A, Murphy TF (2011) Haemophilus influenzae infections in the H. Influenzae type b conjugate vaccine era. J Clin Microbiol 49(11):3728\u20133732","journal-title":"J Clin Microbiol"},{"issue":"8","key":"3362_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.tim.2007.06.004","volume":"15","author":"AL Erwin","year":"2007","unstructured":"Erwin AL, Smith AL (2007) Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol 15(8):355\u2013362","journal-title":"Trends Microbiol"},{"issue":"1","key":"3362_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/jac\/dkf133","volume":"50","author":"H Lode","year":"2002","unstructured":"Lode H, Allewelt M (2002) Role of newer fluoroquinolones in lower respiratory tract infections. J Antimicrob Chemother 50(1):151\u2013154","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3362_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jac\/49.1.31","volume":"49","author":"P Ball","year":"2002","unstructured":"Ball P, Baquero F, Cars O, File T, Garau J, Klugman K, Low DE, Rubinstein E, Wise R, Consensus Group on R, Prescribing in Respiratory Tract I (2002) Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 49(1):31\u201340","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"3362_CR6","doi-asserted-by":"publisher","first-page":"118 e119","DOI":"10.1016\/j.cmi.2016.10.009","volume":"23","author":"A Cherkaoui","year":"2017","unstructured":"Cherkaoui A, Diene SM, Renzoni A, Emonet S, Renzi G, Francois P, Schrenzel J (2017) Imipenem heteroresistance in nontypeable Haemophilus influenzae is linked to a combination of altered PBP3, slow drug influx and direct efflux regulation. Clin Microbiol Infect 23(2):118 e119","journal-title":"Clin Microbiol Infect"},{"issue":"7501","key":"3362_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature13205","volume":"509","author":"D Du","year":"2014","unstructured":"Du D, Wang Z, James NR, Voss JE, Klimont E, Ohene-Agyei T, Venter H, Chiu W, Luisi BF (2014) Structure of the AcrAB-TolC multidrug efflux pump. Nature 509(7501):512\u2013515","journal-title":"Nature"},{"issue":"2","key":"3362_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/CMR.00040-06","volume":"20","author":"S Tristram","year":"2007","unstructured":"Tristram S, Jacobs MR, Appelbaum PC (2007) Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 20(2):368\u2013389","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"3362_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/106002809302700311","volume":"27","author":"SL Barriere","year":"1993","unstructured":"Barriere SL, Hindler JA (1993) Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease. Ann Pharmacother 27(3):309\u2013310","journal-title":"Ann Pharmacother"},{"issue":"2","key":"3362_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/jac\/39.2.292","volume":"39","author":"HJ Bootsma","year":"1997","unstructured":"Bootsma HJ, Troelstra A, van Veen-Rutgers A, Mooi FR, de Neeling AJ, Overbeek BP (1997) Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from the Netherlands. J Antimicrob Chemother 39(2):292\u2013293","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3362_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0732-8893(03)00016-6","volume":"46","author":"DJ Biedenbach","year":"2003","unstructured":"Biedenbach DJ, Jones RN (2003) Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 46(1):55\u201361","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"3362_CR12","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1086\/420820","volume":"38","author":"J Nazir","year":"2004","unstructured":"Nazir J, Urban C, Mariano N, Burns J, Tommasulo B, Rosenberg C, Segal-Maurer S, Rahal JJ (2004) Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology. Clin Infect Dis 38(11):1564\u20131569","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3362_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1128\/AAC.04005-14","volume":"59","author":"C Puig","year":"2015","unstructured":"Puig C, Tirado-Velez JM, Calatayud L, Tubau F, Garmendia J, Ardanuy C, Marti S, de la Campa AG, Linares J (2015) Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother 59(1):461\u2013466","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"3362_CR14","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1128\/AAC.40.7.1741","volume":"40","author":"M Georgiou","year":"1996","unstructured":"Georgiou M, Munoz R, Roman F, Canton R, Gomez-Lus R, Campos J, De La Campa AG (1996) Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob Agents Chemother 40(7):1741\u20131744","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3362_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1128\/JCM.01561-07","volume":"46","author":"S Yokota","year":"2008","unstructured":"Yokota S, Ohkoshi Y, Sato K, Fujii N (2008) Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children. J Clin Microbiol 46(1):361\u2013365","journal-title":"J Clin Microbiol"},{"key":"3362_CR16","doi-asserted-by":"crossref","unstructured":"Tsuji BT, Fisher J, Boadi-Yeboah R, Holden PN, Sethi S, Pettigrew MM, Murphy TF (2018) Azithromycin pharmacodynamics against persistent Haemophilus influenzae in chronic obstructive pulmonary disease. Antimicrob Agents Chemother 62(2)","DOI":"10.1128\/AAC.01995-17"},{"issue":"12","key":"3362_CR17","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1093\/jac\/dkx290","volume":"72","author":"CT Atkinson","year":"2017","unstructured":"Atkinson CT, Kunde DA, Tristram SG (2017) Expression of acquired macrolide resistance genes in Haemophilus influenzae. J Antimicrob Chemother 72(12):3298\u20133301","journal-title":"J Antimicrob Chemother"},{"key":"3362_CR18","unstructured":"EUCAST (2003) Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution"},{"key":"3362_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jgar.2015.12.004","volume":"5","author":"K Fuursted","year":"2016","unstructured":"Fuursted K, Hartmeyer GN, Stegger M, Andersen PS, Justesen US (2016) Molecular characterisation of the clonal emergence of high-level ciprofloxacin-monoresistant Haemophilus influenzae in the region of southern Denmark. J Glob Antimicrob Resist 5:67\u201370","journal-title":"J Glob Antimicrob Resist"},{"key":"3362_CR20","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3389\/fmicb.2017.02676","volume":"8","author":"A Cherkaoui","year":"2017","unstructured":"Cherkaoui A, Diene SM, Fischer A, Leo S, Francois P, Schrenzel J (2017) Transcriptional modulation of penicillin-binding protein 1b, outer membrane protein P2 and efflux pump (AcrAB-TolC) during heat stress is correlated to enhanced bactericidal action of imipenem on non-typeable Haemophilus influenzae. Front Microbiol 8:2676","journal-title":"Front Microbiol"},{"issue":"9","key":"3362_CR21","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1128\/AAC.48.9.3570-3572.2004","volume":"48","author":"X Li","year":"2004","unstructured":"Li X, Mariano N, Rahal JJ, Urban CM, Drlica K (2004) Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV. Antimicrob Agents Chemother 48(9):3570\u20133572","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3362_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jiac.2013.12.007","volume":"20","author":"H Shoji","year":"2014","unstructured":"Shoji H, Shirakura T, Fukuchi K, Takuma T, Hanaki H, Tanaka K, Niki Y (2014) A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in quinolone resistance-determining regions. J Infect Chemother 20(4):250\u2013255","journal-title":"J Infect Chemother"},{"issue":"9","key":"3362_CR23","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1128\/AAC.00335-07","volume":"51","author":"M Cerquetti","year":"2007","unstructured":"Cerquetti M, Giufre M, Cardines R, Mastrantonio P (2007) First characterization of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates. Antimicrob Agents Chemother 51(9):3155\u20133161","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3362_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1128\/AAC.45.6.1693-1699.2001","volume":"45","author":"K Ubukata","year":"2001","unstructured":"Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, Sunakawa K, Inoue M, Konno M (2001) Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 45(6):1693\u20131699","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"3362_CR25","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1128\/AAC.49.7.2834-2839.2005","volume":"49","author":"Y Osaki","year":"2005","unstructured":"Osaki Y, Sanbongi Y, Ishikawa M, Kataoka H, Suzuki T, Maeda K, Ida T (2005) Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob Agents Chemother 49(7):2834\u20132839","journal-title":"Antimicrob Agents Chemother"},{"key":"3362_CR26","doi-asserted-by":"crossref","unstructured":"Kitaoka K, Kimura K, Kitanaka H, Banno H, Jin W, Wachino JI, Arakawa Y (2018) Carbapenem-non-susceptible Haemophilus influenzae with penicillin-binding protein 3 containing amino acid insertion. Antimicrob Agents Chemother","DOI":"10.1128\/AAC.00671-18"},{"issue":"7378","key":"3362_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nature10641","volume":"480","author":"R Nakashima","year":"2011","unstructured":"Nakashima R, Sakurai K, Yamasaki S, Nishino K, Yamaguchi A (2011) Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature 480(7378):565\u2013569","journal-title":"Nature"},{"key":"3362_CR28","doi-asserted-by":"crossref","unstructured":"Seyama S, Wajima T, Nakaminami H, Noguchi N (2017) Amino acid substitution in the major multidrug efflux transporter protein AcrB contributes to low susceptibility to azithromycin in Haemophilus influenzae. Antimicrob Agents Chemother 61(11)","DOI":"10.1128\/AAC.01337-17"},{"issue":"1","key":"3362_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1054\/drup.1998.0068","volume":"2","author":"DC Hooper","year":"1999","unstructured":"Hooper DC (1999) Mechanisms of fluoroquinolone resistance. Drug Resist Updat 2(1):38\u201355","journal-title":"Drug Resist Updat"},{"issue":"3","key":"3362_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1128\/AAC.43.3.530","volume":"43","author":"T Akasaka","year":"1999","unstructured":"Akasaka T, Onodera Y, Tanaka M, Sato K (1999) Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV. Antimicrob Agents Chemother 43(3):530\u2013536","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3362_CR31","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1128\/AAC.45.12.3544-3547.2001","volume":"45","author":"M Takei","year":"2001","unstructured":"Takei M, Fukuda H, Kishii R, Hosaka M (2001) Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition. Antimicrob Agents Chemother 45(12):3544\u20133547","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"3362_CR32","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1128\/AAC.42.8.1917","volume":"42","author":"H Fukuda","year":"1998","unstructured":"Fukuda H, Hori S, Hiramatsu K (1998) Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus. Antimicrob Agents Chemother 42(8):1917\u20131922","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3362_CR33","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1128\/AAC.41.5.1166","volume":"41","author":"B Perichon","year":"1997","unstructured":"Perichon B, Tankovic J, Courvalin P (1997) Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 41(5):1166\u20131167","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3362_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jac\/41.1.49","volume":"41","author":"H Takahashi","year":"1998","unstructured":"Takahashi H, Kikuchi T, Shoji S, Fujimura S, Lutfor AB, Tokue Y, Nukiwa T, Watanabe A (1998) Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 41(1):49\u201357","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3362_CR35","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1128\/AAC.49.8.3129-3135.2005","volume":"49","author":"CR Dean","year":"2005","unstructured":"Dean CR, Narayan S, Daigle DM, Dzink-Fox JL, Puyang X, Bracken KR, Dean KE, Weidmann B, Yuan Z, Jain R, Ryder NS (2005) Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415. Antimicrob Agents Chemother 49(8):3129\u20133135","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3362_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12275-015-4498-5","volume":"53","author":"YK Park","year":"2015","unstructured":"Park YK, Ko KS (2015) Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin. J Microbiol 53(1):53\u201359","journal-title":"J Microbiol"},{"issue":"5","key":"3362_CR37","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1128\/AAC.00163-16","volume":"60","author":"S Seyama","year":"2016","unstructured":"Seyama S, Wajima T, Nakaminami H, Noguchi N (2016) Clarithromycin resistance mechanisms of epidemic beta-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae strains in Japan. Antimicrob Agents Chemother 60(5):3207\u20133210","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3362-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3362-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3362-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T19:04:01Z","timestamp":1566673441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3362-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,25]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3362"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3362-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,25]]},"assertion":[{"value":"18 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}